Design, Synthesis and Biological Evaluation of Pazopanib Derivatives as Antitumor Agents
作者:Yuping Jia、Jian Zhang、Jinhong Feng、Fuming Xu、Huili Pan、Wenfang Xu
DOI:10.1111/cbdd.12243
日期:2014.3
A novel series of pazopanib derivatives were designed, synthesized, and evaluated for their inhibitory activity against a series of kinases including VEGFR‐2, EGFR, AKT1, ALK1, and ABL1. The anti‐angiogenic activities ex vivo of some compounds were also investigated. Compounds P2d and P2e demonstrated outstanding inhibitory activity against VEGFR‐2 and ABL1 and higher anti‐angiogenic activity compared with Pazopanib, the reference standard. These two compounds (P2d and P2e) could be used as novel lead compounds for further development of anticancer agents.